[1] | Gaffen AS, Haas DA. Survey of local anesthetic use by Ontario dentists. JCDA 2009;75 (9):649. |
|
[2] | Heavner JE. Local anesthetics. Current Opinion in Anaesthesiology 2007; 20:336-342. |
|
[3] | Malamend ST. (2013). Technique of maxillary anesthesia In Malamed ST. Hand book of local anesthesia. 6th edition .Mosby Elsevir Inc, New York, 2013. |
|
[4] | Shaban B, Moradi E, Nejat AH. Hemodynamic effect of 2% lidocaine with 1:80,000 epinephrin infiltration in maxillofacial surgeries under general anesthesia. JDMT 2013;2(1):17-20. |
|
[5] | Logothetis RM. (2011). Local anesthetic agent: A review of the current options for dental hygienistis. Journal of the California dental hygienists association 2011; 27(2):1-10. |
|
[6] | Dufour E, Villard-Saussine S, Mellon V. Opiorphin secretion pattern in healthy volunteers: gender difference and organ specificity. Biochem Anal Biochem 2013; 2(3):2-11. |
|
[7] | Monaco G, Dapril G, Tavern L. Mandibular third molar removal in young patients, an evaluation of 2 different flap designs. J Oral Maxillo Fac Surg, 2009; 67:15-21. |
|
[8] | Martin W, Heymans M, Skorpil N. Can a single pain rating replace a multiple pain rating in third molar surgery studies. Int J Oral Maxillo Fac Surg 2012; 41:1010-1013. |
|
[9] | Kanegane K, Penha S, Borsatti M. Dental anxiety in an emergency dental service.Rev Saude Publica 2003; 37:786-792. |
|
[10] | Nater YM, Rohleder N, Gaab J. Human salivary alpha – amylase reactivity in a psychosocial stress paradiagn. Int J Psychophysiol 2005; 55(3):333-341. |
|
[11] | Nayyar MS, Yates C. Bupivacaine as preemptive analgesia in third molar surgery, randomized control trail. Br J Oral Maxillo Fac Surg 2006; 44:501-503. |
|
[12] | Brkljacic LL, Sabalic MM, Salaric II. Development and validation of a liquid chromatography- tandem mass spectrometry method for the quantification of opiorphin in human saliva. J Chromatogr B Analyt Technol Biomed Life Sci 2011; 879 (32):3920-3926. |
|
[13] | Malamend SF. Buffering local anesthetics in dentistry. The pulse 2011; 44(1):8-9. |
|
[14] | American Academy of Pediatric Dentistry AADP. Clinical guide lines in guideline on use of local anesthesia for pediatric patient 2009; 34(6):182-186. |
|
[15] | Rougeot C, Robert F, Menz L. Systemically active human opiorphin is a potent yet non – addective analgesic without drug tolerance effects. Journal of Physiology and Pharmacology 2010; 61(4):483-490. |
|
[16] | Wisner A, Dufour E, Messaoudi M. Human opiorphin, a natural antinociceptive modulator of opiod– dependent pathways .PNAS 2006;103(47):17979-17984. |
|
[17] | Noble F, Banisadr G, Jardinand F. First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor. Neuroscience 2001; 105:479-488. |
|
[18] | Noble F, Roques BP. Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drug. Expert Opin Ther Trget 2007; 11:145-159. |
|
[19] | Pinto M, Rougeot C, Gracia L et. al. Proposed bioactive conformation of opiorphin, an endogenous dual APN/NEP inhibitor. Medicinal Chemistry 2012;3 (1):20-24. |
|
[20] | Thanawala V, Kadam VJ, Ghosh R. Enkephalin inhibitors: potential agents for the management of pain .Current Drug Targets 2008; 9(10):887-894. |
|